Using Substances to Cope With the COVID-19 Pandemic: U.S. National Data at Age 19 Years.

Using Substances to Cope With the COVID-19 Pandemic: U.S. National Data at Age 19 Years.
复制标题

DOI:
10.1016/j.jadohealth.2021.11.006
复制
发表时间:
2022-03
期刊:
The Journal of adolescent health : official publication of the Society for Adolescent Medicine
影响因子:
--
通讯作者:
Miech R
Miech R
中科院分区:
其他
文献类型:
--
作者:
Patrick ME;Parks MJ;Fairlie AM;Kreski NT;Keyes KM;Miech R

文献摘要

参考文献

被引文献

相似文献

研究使用药物应对COVID-19大流行的预测因素,包括与大流行相关的隔离、压力、经济困难、人口统计和大流行前药物使用。从2019年春季到2020年秋季(M = 19.6岁),对美国12年级的全国样本(N = 1244)进行了跟踪调查,当时年轻人被问及他们使用大麻、电子烟、饮酒和其他药物来应对的情况。在2020年秋季,15.7%的人报告使用大麻,8.9%的人增加了电子烟,8.2%的人增加了饮酒,以应对社交距离和隔离。在控制人口统计学和大流行前物质使用的多变量分析中,与covid相关的隔离与大麻使用相关(优势比= 1.31,95%可信区间= 1.06-1.63),经济困难与饮酒增加相关(优势比= 1.39,95%可信区间= 1.01-1.92)。几乎没有人口统计学上的差异。大多数报告与covid - 19相关物质使用的人(约80%)在大流行之前使用过该物质。年轻人报告使用药物应对COVID-19大流行,特别是如果他们报告在大流行前使用。
To examine predictors of using substances to cope with the COVID-19 pandemic, including pandemic-related isolation, stress, economic hardship, demographics, and prepandemic substance use. A U.S. national sample (N = 1,244) was followed from the 12th grade in Spring 2019 to Fall 2020 (M = 19.6 years) when young adults were asked about their use of marijuana, vaping, drinking, and other drugs to cope. In Fall 2020, 15.7% reported using marijuana, 8.9% increased vaping, and 8.2% increased drinking to cope with social distancing and isolation. In multivariable analyses controlling for demographics and prepandemic substance use, COVID-related isolation was associated with marijuana use (odds ratio = 1.31, 95% confidence interval = 1.06–1.63) and economic hardship with increased drinking (odds ratio = 1.39, 95% confidence interval = 1.01–1.92). There were few demographic differences. Most (>80%) who reported COVID-related substance use coping used that substance before pandemic. Young people reported using substances to cope with the COVID-19 pandemic, especially if they reported prepandemic use.
DOI: 10.1177/2050312120965321
发表时间: 2020
期刊: SAGE open medicine
影响因子: 2.3
作者:
Sharma P;Ebbert JO;Rosedahl JK;Philpot LM
通讯作者: Philpot LM
DOI: 10.1016/j.drugalcdep.2020.108404
发表时间: 2021-01-01
影响因子: 4.2
作者:
Rhew IC;Cadigan JM;Lee CM
通讯作者: Lee CM
DOI: 10.1177/01622439211052867
发表时间: 2021-10-27
影响因子: 3.1
作者:
Rommetveit, Kjetil;Ballo, Ingrid Foss;Sareen, Siddharth
通讯作者: Sareen, Siddharth
DOI: 10.1080/02791072.2020.1836435
发表时间: 2020-10-29
影响因子: 2.8
作者:
Horigian, Viviana E.;Schmidt, Renae D.;Feaster, Daniel J.
通讯作者: Feaster, Daniel J.
DOI: 10.1016/j.drugalcdep.2016.10.042
发表时间: 2017-01-01
影响因子: 4.2
作者:
Carliner, Hannah;Mauro, Pia M.;Hasin, Deborah S.
通讯作者: Hasin, Deborah S.